anmelden
FTSE All-Share
5.509,65
PKT
-11,30
PKT
-0,20
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu FTSE All-Share-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 17.04.24 | Rio Tinto Overweight | JP Morgan Chase & Co. | |
| 17.04.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 17.04.24 | Rio Tinto Overweight | JP Morgan Chase & Co. | |
| 17.04.24 | Rio Tinto Buy | Goldman Sachs Group Inc. | |
| 17.04.24 | Rio Tinto Sector Perform | RBC Capital Markets | |
| 17.04.24 | Rio Tinto Buy | Jefferies & Company Inc. | |
| 16.04.24 | AstraZeneca Hold | Deutsche Bank AG | |
| 16.04.24 | Rio Tinto Overweight | Barclays Capital | |
| 16.04.24 | Glencore Equal Weight | Barclays Capital | |
| 16.04.24 | Rio Tinto Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 15.04.24 | AstraZeneca Overweight | Barclays Capital | |
| 12.04.24 | BP Overweight | Barclays Capital | |
| 12.04.24 | Diageo Sell | Deutsche Bank AG | |
| 12.04.24 | BAE Systems Buy | Deutsche Bank AG | |
| 11.04.24 | Vodafone Group Buy | UBS AG | |
| 10.04.24 | Vodafone Group Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 10.04.24 | HSBC Neutral | JP Morgan Chase & Co. | |
| 09.04.24 | BP Outperform | RBC Capital Markets | |
| 09.04.24 | Rio Tinto Buy | Jefferies & Company Inc. | |
| 09.04.24 | BP Overweight | Barclays Capital | |
| 09.04.24 | HSBC Neutral | JP Morgan Chase & Co. | |
| 09.04.24 | BP Underweight | JP Morgan Chase & Co. | |
| 09.04.24 | HSBC Neutral | UBS AG | |
| 09.04.24 | BP Buy | UBS AG | |
| 09.04.24 | Diageo Hold | Jefferies & Company Inc. | |
| 09.04.24 | BP Buy | Jefferies & Company Inc. | |
| 09.04.24 | BP Underweight | JP Morgan Chase & Co. | |
| 08.04.24 | GSK Equal Weight | Barclays Capital | |
| 08.04.24 | AstraZeneca Overweight | Barclays Capital | |
| 08.04.24 | Unilever Overweight | Barclays Capital | |
| 05.04.24 | Shell (ex Royal Dutch Shell) Overweight | Barclays Capital | |
| 05.04.24 | AstraZeneca Sell | UBS AG | |
| 05.04.24 | National Grid Buy | UBS AG | |
| 05.04.24 | Shell (ex Royal Dutch Shell) Neutral | UBS AG | |
| 05.04.24 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 05.04.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 05.04.24 | Shell (ex Royal Dutch Shell) Buy | Jefferies & Company Inc. | |
| 05.04.24 | BP Underweight | JP Morgan Chase & Co. | |
| 05.04.24 | Shell (ex Royal Dutch Shell) Overweight | JP Morgan Chase & Co. | |
| 04.04.24 | GSK Equal Weight | Barclays Capital |